Prostalene

DB11454

small molecule vet_approved

Deskripsi

Analog of prostaglandin F2 alpha.

Struktur Molekul 2D

Berat 380.525
Wujud -

Peta Jejaring Molekuler
Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

104 Data
Icosapent The therapeutic efficacy of Prostalene can be decreased when used in combination with Icosapent.
Indomethacin The therapeutic efficacy of Prostalene can be decreased when used in combination with Indomethacin.
Nabumetone The therapeutic efficacy of Prostalene can be decreased when used in combination with Nabumetone.
Ketorolac The therapeutic efficacy of Prostalene can be decreased when used in combination with Ketorolac.
Tenoxicam The therapeutic efficacy of Prostalene can be decreased when used in combination with Tenoxicam.
Celecoxib The therapeutic efficacy of Prostalene can be decreased when used in combination with Celecoxib.
Tolmetin The therapeutic efficacy of Prostalene can be decreased when used in combination with Tolmetin.
Rofecoxib The therapeutic efficacy of Prostalene can be decreased when used in combination with Rofecoxib.
Piroxicam The therapeutic efficacy of Prostalene can be decreased when used in combination with Piroxicam.
Fenoprofen The therapeutic efficacy of Prostalene can be decreased when used in combination with Fenoprofen.
Valdecoxib The therapeutic efficacy of Prostalene can be decreased when used in combination with Valdecoxib.
Diclofenac The therapeutic efficacy of Prostalene can be decreased when used in combination with Diclofenac.
Sulindac The therapeutic efficacy of Prostalene can be decreased when used in combination with Sulindac.
Flurbiprofen The therapeutic efficacy of Prostalene can be decreased when used in combination with Flurbiprofen.
Etodolac The therapeutic efficacy of Prostalene can be decreased when used in combination with Etodolac.
Mefenamic acid The therapeutic efficacy of Prostalene can be decreased when used in combination with Mefenamic acid.
Naproxen The therapeutic efficacy of Prostalene can be decreased when used in combination with Naproxen.
Sulfasalazine The therapeutic efficacy of Prostalene can be decreased when used in combination with Sulfasalazine.
Phenylbutazone The therapeutic efficacy of Prostalene can be decreased when used in combination with Phenylbutazone.
Meloxicam The therapeutic efficacy of Prostalene can be decreased when used in combination with Meloxicam.
Carprofen The therapeutic efficacy of Prostalene can be decreased when used in combination with Carprofen.
Diflunisal The therapeutic efficacy of Prostalene can be decreased when used in combination with Diflunisal.
Salicylic acid The therapeutic efficacy of Prostalene can be decreased when used in combination with Salicylic acid.
Meclofenamic acid The therapeutic efficacy of Prostalene can be decreased when used in combination with Meclofenamic acid.
Acetylsalicylic acid The therapeutic efficacy of Prostalene can be decreased when used in combination with Acetylsalicylic acid.
Oxaprozin The therapeutic efficacy of Prostalene can be decreased when used in combination with Oxaprozin.
Ketoprofen The therapeutic efficacy of Prostalene can be decreased when used in combination with Ketoprofen.
Balsalazide The therapeutic efficacy of Prostalene can be decreased when used in combination with Balsalazide.
Ibuprofen The therapeutic efficacy of Prostalene can be decreased when used in combination with Ibuprofen.
Lumiracoxib The therapeutic efficacy of Prostalene can be decreased when used in combination with Lumiracoxib.
Magnesium salicylate The therapeutic efficacy of Prostalene can be decreased when used in combination with Magnesium salicylate.
Salsalate The therapeutic efficacy of Prostalene can be decreased when used in combination with Salsalate.
Choline magnesium trisalicylate The therapeutic efficacy of Prostalene can be decreased when used in combination with Choline magnesium trisalicylate.
Antrafenine The therapeutic efficacy of Prostalene can be decreased when used in combination with Antrafenine.
Aminophenazone The therapeutic efficacy of Prostalene can be decreased when used in combination with Aminophenazone.
Antipyrine The therapeutic efficacy of Prostalene can be decreased when used in combination with Antipyrine.
Tiaprofenic acid The therapeutic efficacy of Prostalene can be decreased when used in combination with Tiaprofenic acid.
Etoricoxib The therapeutic efficacy of Prostalene can be decreased when used in combination with Etoricoxib.
Taxifolin The therapeutic efficacy of Prostalene can be decreased when used in combination with Taxifolin.
Oxyphenbutazone The therapeutic efficacy of Prostalene can be decreased when used in combination with Oxyphenbutazone.
Licofelone The therapeutic efficacy of Prostalene can be decreased when used in combination with Licofelone.
Nimesulide The therapeutic efficacy of Prostalene can be decreased when used in combination with Nimesulide.
Benoxaprofen The therapeutic efficacy of Prostalene can be decreased when used in combination with Benoxaprofen.
Zomepirac The therapeutic efficacy of Prostalene can be decreased when used in combination with Zomepirac.
Cimicoxib The therapeutic efficacy of Prostalene can be decreased when used in combination with Cimicoxib.
Lornoxicam The therapeutic efficacy of Prostalene can be decreased when used in combination with Lornoxicam.
Aceclofenac The therapeutic efficacy of Prostalene can be decreased when used in combination with Aceclofenac.
Zaltoprofen The therapeutic efficacy of Prostalene can be decreased when used in combination with Zaltoprofen.
Azapropazone The therapeutic efficacy of Prostalene can be decreased when used in combination with Azapropazone.
Parecoxib The therapeutic efficacy of Prostalene can be decreased when used in combination with Parecoxib.
Salicylamide The therapeutic efficacy of Prostalene can be decreased when used in combination with Salicylamide.
Kebuzone The therapeutic efficacy of Prostalene can be decreased when used in combination with Kebuzone.
Isoxicam The therapeutic efficacy of Prostalene can be decreased when used in combination with Isoxicam.
Indoprofen The therapeutic efficacy of Prostalene can be decreased when used in combination with Indoprofen.
Ibuproxam The therapeutic efficacy of Prostalene can be decreased when used in combination with Ibuproxam.
Floctafenine The therapeutic efficacy of Prostalene can be decreased when used in combination with Floctafenine.
Fenbufen The therapeutic efficacy of Prostalene can be decreased when used in combination with Fenbufen.
Etofenamate The therapeutic efficacy of Prostalene can be decreased when used in combination with Etofenamate.
Epirizole The therapeutic efficacy of Prostalene can be decreased when used in combination with Epirizole.
Benzydamine The therapeutic efficacy of Prostalene can be decreased when used in combination with Benzydamine.
Dexibuprofen The therapeutic efficacy of Prostalene can be decreased when used in combination with Dexibuprofen.
Dexketoprofen The therapeutic efficacy of Prostalene can be decreased when used in combination with Dexketoprofen.
Droxicam The therapeutic efficacy of Prostalene can be decreased when used in combination with Droxicam.
Tolfenamic acid The therapeutic efficacy of Prostalene can be decreased when used in combination with Tolfenamic acid.
Firocoxib The therapeutic efficacy of Prostalene can be decreased when used in combination with Firocoxib.
Clonixin The therapeutic efficacy of Prostalene can be decreased when used in combination with Clonixin.
Morniflumate The therapeutic efficacy of Prostalene can be decreased when used in combination with Morniflumate.
Propacetamol The therapeutic efficacy of Prostalene can be decreased when used in combination with Propacetamol.
Talniflumate The therapeutic efficacy of Prostalene can be decreased when used in combination with Talniflumate.
Robenacoxib The therapeutic efficacy of Prostalene can be decreased when used in combination with Robenacoxib.
Tepoxalin The therapeutic efficacy of Prostalene can be decreased when used in combination with Tepoxalin.
Flunixin The therapeutic efficacy of Prostalene can be decreased when used in combination with Flunixin.
Polmacoxib The therapeutic efficacy of Prostalene can be decreased when used in combination with Polmacoxib.
Nitroaspirin The therapeutic efficacy of Prostalene can be decreased when used in combination with Nitroaspirin.
Indobufen The therapeutic efficacy of Prostalene can be decreased when used in combination with Indobufen.
Ebselen The therapeutic efficacy of Prostalene can be decreased when used in combination with Ebselen.
Tinoridine The therapeutic efficacy of Prostalene can be decreased when used in combination with Tinoridine.
Alclofenac The therapeutic efficacy of Prostalene can be decreased when used in combination with Alclofenac.
Fentiazac The therapeutic efficacy of Prostalene can be decreased when used in combination with Fentiazac.
Suxibuzone The therapeutic efficacy of Prostalene can be decreased when used in combination with Suxibuzone.
Bumadizone The therapeutic efficacy of Prostalene can be decreased when used in combination with Bumadizone.
Alminoprofen The therapeutic efficacy of Prostalene can be decreased when used in combination with Alminoprofen.
Difenpiramide The therapeutic efficacy of Prostalene can be decreased when used in combination with Difenpiramide.
Nifenazone The therapeutic efficacy of Prostalene can be decreased when used in combination with Nifenazone.
Lonazolac The therapeutic efficacy of Prostalene can be decreased when used in combination with Lonazolac.
Tenidap The therapeutic efficacy of Prostalene can be decreased when used in combination with Tenidap.
Propyphenazone The therapeutic efficacy of Prostalene can be decreased when used in combination with Propyphenazone.
Proglumetacin The therapeutic efficacy of Prostalene can be decreased when used in combination with Proglumetacin.
Guacetisal The therapeutic efficacy of Prostalene can be decreased when used in combination with Guacetisal.
Ethenzamide The therapeutic efficacy of Prostalene can be decreased when used in combination with Ethenzamide.
Carbaspirin calcium The therapeutic efficacy of Prostalene can be decreased when used in combination with Carbaspirin calcium.
Mofebutazone The therapeutic efficacy of Prostalene can be decreased when used in combination with Mofebutazone.
Proquazone The therapeutic efficacy of Prostalene can be decreased when used in combination with Proquazone.
Benorilate The therapeutic efficacy of Prostalene can be decreased when used in combination with Benorilate.
Pirprofen The therapeutic efficacy of Prostalene can be decreased when used in combination with Pirprofen.
Acemetacin The therapeutic efficacy of Prostalene can be decreased when used in combination with Acemetacin.
Imidazole salicylate The therapeutic efficacy of Prostalene can be decreased when used in combination with Imidazole salicylate.
SC-236 The therapeutic efficacy of Prostalene can be decreased when used in combination with SC-236.
NS-398 The therapeutic efficacy of Prostalene can be decreased when used in combination with NS-398.
Flurbiprofen axetil The therapeutic efficacy of Prostalene can be decreased when used in combination with Flurbiprofen axetil.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 16726434
    Ley WB, Purswell BJ, Bowen JM: The effects of prostalene and alfaprostol as uterine myotonics, and the effect on postpartum pregnancy rate in the mare following daily treatment with prostalene. Theriogenology. 1988;29(5):1113-21.
  • PMID: 1049488
    Averkin G, Schiltz R: Summary of the effect of prostalene, a new synthetic prostaglandin, on the breeding efficiency of mares. Vet Med Small Anim Clin. 1976 Nov;71(11):1616, 1621-3.
  • PMID: 121604
    Vickery BH, McRae GI, Bajka A: Luteolysis and termination of early pregnancy in the rhesus monkey with prostalene, a synthetic prostaglandin analog. Prostaglandins Med. 1979 Mar;2(3):191-201.
  • PMID: 17422207
    Bosu WT, McKinnon AO: Induction of abortion during midgestation in mares. Can Vet J. 1982 Dec;23(12):358-60.
  • PMID: 16725656
    Hamm D, Witherspoon DM, Buell JR, Chen CL, Jochle W: Determination of clinical and luteolytic effectiveness of a prostaglandin analog in mares by a dose response study. Theriogenology. 1981 Oct;16(4):447-57.
  • PMID: 289794
    Loy RG, Buell JR, Stevenson W, Hamm D: Sources of variation in response intervals after prostaglandin treatment in mares with functional corpora lutea. J Reprod Fertil Suppl. 1979;(27):229-35.
  • PMID: 7341563
    Imel KJ, Squires EL, Elsden RP, Shideler RK: Collection and transfer of equine embryos. J Am Vet Med Assoc. 1981 Nov 15;179(10):987-91.
  • PMID: 550139
    Vickery B, Briones W, Holstein A: Opposite and mutually antagonistic effects on uterine contractility of two epimeric forms of a synthetic prostaglandin analog. Prostaglandins Med. 1979 Jan;2(1):3-10.

Contoh Produk & Brand

Produk: 0 • International brands: 1
International Brands
  • Synchrocept

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul